Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Topical tofacitinib cream may help treat certain hair loss conditions with fewer risks.

A stable and simple finasteride suspension was developed that retains over 94.3% of its concentration for up to 90 days and doesn't significantly increase occupational exposure, but safety measures are still advised.

Intralesional Triamcinolone acetonide injections are safe and effective for treating alopecia areata.

Tofacitinib was more effective than methotrexate for treating alopecia areata.

Treatment with prednisolone and dapsone stopped new blisters and partially healed previous ones.

Liposomes are not better than acetone for applying DHT on skin.

High-dose steroid pulse therapy effectively regrows hair in severe multifocal alopecia areata.

The combination treatment was more effective for scalp hair regrowth but caused more irritation.

Cyclosporine effectively treated a woman's stubborn skin condition.

An 8-year-old with severe hair loss regrew all hair after six months of tofacitinib treatment.

FCO2 laser is a better treatment for alopecia areata than intralesional steroids.

Ethinylestradiol/chlormadinone acetate may be an effective and well-tolerated treatment for skin conditions caused by excess androgens.

Liposomes with minoxidil and PEP penetrate skin slowly but reach deeper layers than foam.

High potency topical steroids are the most effective treatment for pediatric alopecia areata.

Method B with propylene glycol is better for stable low-concentration DPCP solutions for alopecia areata.

Tempol is safe and may prevent hair loss from brain radiotherapy.

Scalp psoriasis treatments like strong corticosteroids and vitamin D3 analogues are effective, especially when combined.

The emu oil emulsion with minoxidil was better at promoting hair growth than the commercial product.

The conclusion is that high-potency steroids or tacrolimus are effective treatments for erosive pustular dermatosis of the scalp.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

Corticosteroids effectively treated a 60-year-old man's skin condition.

DCP in isopropanol is better tolerated for treating alopecia areata.

Valproic acid microemulsions improve skin delivery compared to regular solutions.

Hair regrowth was achieved using 5-Fluorouracil and Bleomycin for scalp atrophy caused by corticosteroids.

A hair growth ointment improved hair length in a family with a genetic hair growth condition.

Topical valproate can effectively promote hair growth.

Applying 2% tofacitinib cream helped some children with severe hair loss grow back hair.

The combined therapy was effective and safe for children with severe alopecia areata.